BIOFARM
96 articole · RSS
SIF Moldova Sells All Its Shares In Biofarm To SIF Banat-Crisana
Regional investment fund SIF Moldova (SIF2.RO) sold its 11.7% stake in Romanian pharmaceutical producer Biofarm Bucuresti (BIO.RO) to regional investment fund SIF Banat-Crisana (SIF1.RO), at...
Biofarm Net Profit Grows 46% in 1Q, to RON16.2M
Romanian pharmaceutical producer Biofarm (BIO.RO) on Wednesday reported a net profit of RON16.2 million for the first quarter, up 46% compared with the same period last year.
Biofarm Appoints Catalin Vicol as General Manager Starting Nov 15
Romanian pharmaceutical producer Biofarm (BIO.RO), controlled by three regional investment funds, of SIFs, has appointed Catalin Vicol as general manager effective November 15.
Biofarm Proposes RON18.7M Dividends At 6% Yield
Romanian pharmaceutical producer Biofarm (BIO.RO) proposes the payment of a gross dividend of RON0.019 per share, at a 6.16% yield, totaling RON18.7 million, which translates into a distribu...
Biofarm 2017 Turnover Up 12% At RON170M; Net Profit Up 24% At RON36M
Romanian pharmaceutical producer Biofarm (BIO.RO) registered 12% higher sales revenue, of RON170 million, and 24% higher net profit, of RON36 million, in 2017. Its debts rose from RON42 mill...
SIF Banat-Crisana Increases Stake In Biofarm By 1.16%
Romanian regional investment fund SIF Banat-Crisana (SIF1.RO) has recently bought a stake of 11.44 million shares of pharmaceutical producer Biofarm Bucuresti (BIO.RO), which represents 1.16...
Biofarm Profit Up 1% To RON15.2M In 1H
Romanian pharmaceutical producer Biofarm (BIO.RO) reported a profit of RON15.2 million in the first six months of the year, up 1% compared with January-June 2015, the company said Friday.
Biofarm Profit Drops 52% To RON6.5M In 1Q
Romanian pharmaceutical producer Biofarm (BIO.RO) reported a profit of RON6.49 million in the first quarter of the year, down 52% compared with January-March 2015, the company said on Tuesda...
Biofarm Eyes RON150M Sales In 2016
Romanian pharmaceutical producer Biofarm (BIO.RO) targets sales of RON150.8 million, exploitation expenses of RON122 million and an operating profit of RON28.8 million this year.